PATENT CLAIM ANALYSIS

Application Number: 16291432
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["424", "442000"]

Abstract:
The invention relates to a composition and a method for manufacturing semi-dry or dry particles containing a mucoadhesive polymer and a bioactive agent such as, but not limited to, an Immunogenic Substance (e.g., a vaccine), that allows the oral or nasal administration and delivery of the bioactive agent essentially unaltered to mucosal surfaces in the animal, including an aquatic animal.

Claim (Index 19):
The method of  claim 14 , wherein the immunogenic substance consists of the vaccine, the cross-linked mucoadhesive polymer, the one or more sugars, the one or more oligosaccharides and the one or more electrolytes, wherein the one or more sugars are selected from the group consisting of fructose, sucrose, dextrose, and trehalose, wherein the one or more oligosaccharides are selected from the group consisting of inulin and fructooligosaccharides (FOS), and wherein the mucoadhesive polymer is a polymer that is not a dimer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.38776
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13260661', '14305406', '13466279', '13204745', '12409607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7340666182153837
- 35 USC 102 Novelty (BERT): 0.5757179349565674
- Combined Prediction Score: 0.7182317498895021
- Mean Citation Score: 309.9065720000001
- Max Citation Score: 479.5791
- Similarity Product: 376.1376468246102

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test